Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Virpax Reveals Results From A Beagle Dog Dose Range Finding Study; All The Dogs In DRF Study Demonstrated Positive Tolerance To Probudur And No Adverse Effects Were Noted

Author: Benzinga Newsdesk | March 18, 2025 04:03pm

Probudur is the company's long-acting liposomal bupivacaine formulation injected at a wound site to provide both immediate and extended pain relief.

The Company continues to work towards its Investigational New Drug (IND) application and this was another important step towards that milestone.

Posted In: VRPX